The goal of this program is to improve the knowledge and competence of cardiologists, internists, hospitalists, and other clinicians on new and emerging treatment strategies to reduce HF-related hospitalization and death.

In this series, Dr. John B. Buse, Dr. Kathleen Dungan, and Dr. Christian T. Ruff present patient cases and share their personal approaches to reducing the risk of cardiovascular disease in diabetic patients. Using real-world evidence, they review cardiovascular risk stratification, the efficacy and safety of GLP-1 RA and cardiovascular outcomes trials, and COVID-19 implications as they develop a comprehensive treatment plan for a patient with cardiovascular risk factors.

This case-based enduring simulcast will cover the treatment and management of patients with type 2 diabetes mellitus.